2-Year Efficacy and Safety of Linagliptin Compared With Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled on Metformin: A Randomized, Double-Blind, Non-Inferiority Trial

Study Questions:

What is the long-term efficacy and safety of linagliptin compared with a commonly used sulphonylurea (glimepiride) as second-line treatment in participants with type 2 diabetes inadequately controlled on metformin?